盐度和营养对凡纳滨对虾蜕壳和生长的影响

采用实验生态学方法以初始体质量为(2.01±0.02) g的凡纳滨对虾为研究对象,投喂不同蛋白水平饲料,实验周期30 d,研究了盐度和饲料蛋白水平对凡纳滨对虾蜕壳和生长的影响。实验采用5×3析因设计,盐度梯度设置为6、12、18、24、30五个水平,饲料蛋白水平梯度设置为30%、36%、42%三个水平。结果表明:(1) 对虾蜕壳相对增重率呈现出随盐度上升而降低的变化趋势,以盐度为6时蜕壳相对增重率为最高。盐度和饲料蛋白水平及其交互作用对实验对虾蜕壳相对增重率影响差异显著(P＜0.05);对虾的特定生长率随盐度升高而上升,盐度和饲料蛋白水平对特定生长率影响差异显著(P＜0.05),其交互作用对特定生长率影响差异不显著。(2) 实验对虾的蜕壳频率,在低盐度水平下随盐度的增加而显著增加(P＜0.05),盐度18时蜕壳频率达到最高,之后随盐度的升高蜕壳频率下降,差异不显著。各盐度水平下,以中等蛋白质水平饲料组(36%)对虾蜕壳频率较高。方差分析表明,盐度和饲料蛋白水平对蜕壳频率影响差异显著(P＜0.05),其交互作用对蜕壳频率影响差异不显著。(3) 对虾蜕壳间期随盐度升高呈先延长后缩短的变化趋势。盐度对对虾蜕壳间期影响差异显著(P＜0.05),饲料蛋白水平单因子以及它和盐度的交互作用对对虾蜕壳间期影响不显著。     

两种盐度下凡纳滨对虾饲料中的最适动植物蛋白比

试验研究了不同盐度下（3和22），以鱼粉和大豆浓缩蛋白为蛋白源，配制6种不同动植物蛋白比的饲料对凡纳滨对虾生长、成活和肝胰腺可溶性蛋白质含量的影响，饲养试验为期40 d。结果显示：（1）饲料动植物蛋白比可显著影响凡纳滨对虾增重率、成活率、肝体指数、肥满度和肝胰腺中可溶性蛋白质含量。增重率随饲料动植物蛋白比升高而升高，但当饲料中动植物蛋白比升至29∶8时，增重率不再明显升高，其它指标均先随饲料动植物蛋白比升高至一定程度，而后则稍有下降；（2）盐度22组对虾的增重率、成活率和肥满度显著高于盐度3组对虾，肝体指数却显著低于盐度3组，不同的盐度对凡纳滨对虾肝胰腺可溶性蛋白含量的影响不显著；（3）双因素方差分析结果显示，盐度和饲料动植物蛋白比对凡纳滨对虾增重率、成活率和肝体指数存在显著交互作用，最大值分别出现在盐度22下全动物蛋白饲料组、盐度22下全动物蛋白和动植物蛋白为29∶8的饲料组、盐度3下饲料动植物蛋白比为14∶23的饲料组中；（4）Broken-Line分析表明，3‰盐度下凡纳滨对虾最适饲料蛋白比为29.12∶7.79~30.29∶6.71，盐度22时为26.05∶10.95~29.03∶7.44。结果提示，饲料中氨基酸的组成和含量会随配方中动植物蛋白配比而改变，且不同盐度下凡纳滨对虾对饲料中动植物蛋白比的要求有所不同，但配饵中适当的动植物蛋白比可以满足虾对各种氨基酸的适宜需求。因此，在养殖过程中，需结合实际的养殖环境和饲料蛋白源种类，来设计适宜的实用饲料配方，这样才能达到降低生产成本，提高经济效益的目的。     

锌对凡纳滨对虾生长、非特异性免疫指标、抗病力及肠道菌群结构的影响

为研究不同锌水平对凡纳滨对虾生长、非特异性免疫指标、抗病力以及肠道菌群结构的影响,实验以ZnSO_4·7H_2O作为锌源,在对虾基础饲料中分别添加0(对照组)、20、40、60、80、100、150 mg/kg有效锌配制成7种等氮等脂饲料,分别投喂初始体质量为(0.45±0.01) g的健康凡纳滨对虾幼虾8周。结果显示:(1)随着饲料中锌水平的提高,对虾增重率(WGR)、特定生长率(SGR)、存活率(SR)和蛋白质效率(PER)呈先上升后下降的趋势,饲料系数(FCR)呈先下降后上升的趋势。其中60 mg/kg组WGR和SGR均显著高于对照组;80 mg/kg组FCR最低,PER和SR最高,均显著优于对照组。(2) 80～150mg/kg组虾体粗脂肪含量显著高于对照组;40～80 mg/kg组虾体粗灰分含量显著高于对照组。(3) 40～150 mg/kg组对虾血清总蛋白(TP)、总胆固醇(TC)及甘油三酯(TG)含量均显著高于对照组。(4)饲料中添加锌提高了血清超氧化物歧化酶(SOD)、酚氧化酶(PO)、碱性磷酸酶(AKP)和酸性磷酸酶(ACP)活性及总抗氧化能力(T-AOC),同时显著降低了血清中的丙二醛(MDA)含量,表明锌可改善凡纳滨对虾的非特异性免疫功能。(5)在人工急性感染哈维氏弧菌的实验中,随着锌水平的提高,对虾存活率呈先上升后下降的趋势,锌添加组存活率均显著高于对照组,且80 mg/kg组存活率最高,抗病力最强。(6)在对虾肠道物种多样性分析中,40和100 mg/kg组对虾肠道有效OTU数目显著高于对照组。随着锌水平的增加,Ace指数和Chao1指数均显著提高,而Shannon指数和Simpson指数无显著变化。研究表明,在本实验条件下,添加适宜水平的锌可促进凡纳滨对虾幼虾的生长、提高抗病力;当饲料中缺乏锌时,对虾的生长和抗病力较差;而过量的锌在一定程度上抑制了对虾的生长,但未出现不良病症。以增重率作为评价指标,饲料中添加94.46 mg/kg锌可显著改善凡纳滨对虾幼虾的生长;以抗病力作为评价依据,凡纳滨对虾幼虾饲料中锌的最适添加量为80 mg/kg。     

凡纳滨对虾幼虾低盐度粗养水体养殖容量的研究

试验设计6个凡纳滨对虾幼虾养殖密度:10、20、30、40、50、60 ind/m2,通过比较60 d养殖周期内的水环境因子、幼虾生长状况与消化酶活性,分析研究凡纳滨对虾幼虾低盐度粗养水体的养殖容量。结果表明:各试验组水质均符合凡纳滨对虾幼虾生长要求,单位水体载虾量主要影响pH、非离子氨氮(NH3-Nm)、溶解氧(DO)等水化指标;不同试验组水体pH、NH3-Nm含量、DO含量、总氮(TN)含量差异极显著(P0.01),浊度、总磷(TP)含量差异显著(P0.05);不同试验组对虾中肠腺蛋白酶活性差异显著(P0.05),表现出单位水体载虾量越高,对虾体内蛋白消化酶活性和氮利用率越低的规律,DO是低盐度粗养水体养殖容量的主要限制因子。综合各项评价指标,得到本试验条件下,凡纳滨对虾幼虾低盐度粗养水体的最佳养殖容量为46.0 g/m3或32.2 g/m2(322 kg/hm2)。     

饲料中黄曲霉毒素B1对凡纳滨对虾生长、肝胰腺和血淋巴生化指标及肝胰腺显微结构的影响

实验设置黄曲霉毒素B1(AFB1)为0、400、800、1200,1600、2000μg/kg6组饲料,饲养初始体质量为(0.3±0.02)g的凡纳滨对虾,经过8周的生长实验观察饲料中AFB1对凡纳滨对虾生长、体营养成分组成、肝胰腺显微结构以及血淋巴和肝胰腺生化指标的影响。实验结果表明:随着饲料中AFB1的增加,各组全虾粗蛋白量无显著性差异,1600μg/kg组和2000μg/kg组的全虾粗脂肪量高于其他组。AFB1为1200μg/kg时对虾增重率最低(304.67%),2000μg/kg时增重率显著高于其他组,但成活率最低(58.33%)。随着饲料中AFB1的升高酶活性普遍呈下降趋势。2000μg/kg组肝胰腺中总抗氧化能力(T-AOC)显著下降(P<0.05),1600μg/kg组肝胰腺中谷胱甘肽S转移酶(GST)、超微量ATP酶和超氧化物歧化酶(SOD)酶活力最低,但血淋巴中GST显著高于其他各组(P<0.05)。从凡纳滨对虾肝胰腺的组织切片可观察到,饲料中含有的AFB1越高,肝胰腺被破坏程度越高。随着饲料中AFB1含量增加,对虾肝胰腺中AFB1残留量逐渐增加,2000μg/kg组对虾肝胰腺中AFB1含量最高(95.49μg/kg),各实验组肌肉中无AFB1残留。     

饲料中不同泛酸水平对凡纳滨对虾生长性能、饲料利用及血清指标的影响

为研究饲料中不同泛酸水平对凡纳滨对虾生长性能、饲料利用及血清指标的影响,实验配制6种等氮等脂(41%粗蛋白质和8%粗脂肪)的实验饲料,泛酸添加水平分别为0(对照组)、50、100、150、300和600 mg/kg,饲料中实测泛酸水平分别为20.9、69.3、99.0、150.2、304.4和513.6 mg/kg。选用初始体质量为(0.73±0.12)g的凡纳滨对虾720尾,随机分为6组(每组3个重复,每个重复40尾),进行为期8周的养殖实验。结果显示,饲料中不同泛酸水平对凡纳滨对虾增重率和特定生长率的影响不显著;对照组凡纳滨对虾成活率显著低于泛酸添加组,然而各泛酸添加组的成活率组间差异不显著。随着泛酸水平从20.9 m.g/kg增加到99.0 mg/kg时,饲料效率和蛋白质效率显著提高,而随着泛酸水平的进一步增加,饲料效率和蛋白质效率显著降低。饲料中泛酸水平对凡纳滨对虾全虾和肌肉主要成分无显著性影响。对照组对虾血清葡萄糖含量显著低于泛酸各添加组,然而泛酸各添加组之间无显著差异;投喂150.2 mg/kg泛酸组血清甘油三酯含量显著低于对照组和513.6 mg/kg;而血清总蛋白和胆固醇含量不受饲料中泛酸水平的影响。随着饲料中泛酸水平由20.9 mg/kg增至150.2 mg/kg,血清超氧化物歧化酶活力显著提高,而随着饲料中泛酸水平的进一步增加,血清超氧化物歧化酶活力显著降低;饲料中泛酸水平为99.0mg/kg组凡纳滨对虾血清总氧化能力显著高于其他各组;投喂对照组和泛酸水平为69.3mg/kg组的凡纳滨对虾血清丙二醛含量最高,投喂泛酸水平为150.2 mg/kg组血清的丙二醛含量显著低于其他各组。以凡纳滨对虾的饲料效率和蛋白质沉积率为评价指标,通过折线模型分析得到凡纳滨对虾泛酸最适需要量分别为113.40和119.87mg/kg。     

硫酸安普霉素对凡纳滨对虾生长、血清生化指标的影响及在组织内的残留

在基础饲料中添加0、60、120、180、240、300mg/kg硫酸安普霉素,投喂初始体质量为(0.51士0.01)g的凡纳滨对虾,记作G0、G50、G120、G180、G240、G300,经49 d养殖试验,研究硫酸安普霉素对凡纳滨对虾生长、血清生化指标的影响及组织中的残留量.结果显示,G180、G240对虾特定生长率和G240蛋白质效率显著高于G0 (P＜0.05);各添加组对虾肝胰指数均高于G0,但差异不显著(P＞0.05).与G0相比,G240全虾粗蛋白、血清总蛋白和甘油三酯含量显著升高(P＜0.05),尿酸水平显著降低(P＜0.05).添加组血清葡萄糖、胆固醇含量和谷草转氨酶、谷丙转氨酶活性与G0相比差异不显著(P＞0.05).各硫酸安普霉素添加组肝胰腺和肌肉中残留量分别为2.92～19.11 μg/g和0.91～8.20 μg/g,并随添加量增加显著升高.结果表明,饲料中添加适量的硫酸安普霉素能显著促进凡纳滨对虾生长性能,不会产生明显的毒性效应,但会在肝胰腺和肌肉中残留.     

抗菌肽对凡纳滨对虾生长和血清非特异性免疫指标的影响

为考察抗菌肽对凡纳滨对虾(Litopenaeus vannamei)生长、饲料利用和免疫能力的影响,分别在基础组饲料中添加0 mg/kg(对照组)、300 mg/kg、400 mg/kg和500 mg/kg抗菌肽,投喂平均体重为(0.8±0.1 g)的凡纳滨对虾6周。结果表明,饲料中添加抗菌肽后,凡纳滨对虾的成活率均显著高于对照组(P<0.05);300 mg/kg抗菌肽组的增重率和饲料系数分别为509.10%、1.33,较对照组提高增重率8.76%(P<0.05),降低饲料系数12.5%(P<0.05),而添加400 mg/kg、500 mg/kg抗菌肽对增重率、饲料系数无显著影响,但显著提高了肌肉粗脂肪含量,各处理组在肌肉粗蛋白、水分含量上无显著差异;300 mg/kg、400 mg/kg抗菌肽组的血清碱性磷酸酶、超氧化物歧化酶、谷丙转氨酶、谷草转氨酶及400 mg/kg抗菌肽组的溶菌酶均显著高于对照组。上述研究表明,饲料中添加300 mg/kg抗菌肽,可显著提高凡纳滨对虾成活率和增重率,降低饲料系数;添加400 mg/kg抗菌肽,对血清非特异性免疫指标有提高作用,凡纳滨对虾饲料中抗菌肽的添加量建议为300～400 mg/kg。     

饲料中添加核苷酸对凡纳滨对虾幼虾生长、肠道形态及抗氧化酶活力的影响

本实验旨在研究外源核苷酸混合物对凡纳滨对虾(Litopenaeus vannamei)幼虾生长性能、体组成、中肠肠道形态和抗氧化酶活力的影响。选取960尾初始体质量为(1.01±0.02)g的凡纳滨对虾,随机分为8组,分别投喂基础饲料和添加5种核苷酸混合物(5′-腺苷酸∶5′-胞苷酸∶5′-尿苷酸二钠∶5′-肌苷酸二钠∶5′-鸟苷酸二钠=1∶1∶1∶1∶1,mix-NT)的实验饲料,各实验组添加量分别为0.1、0.2、0.4、0.6、0.8、1.0和1.2 g/kg饲料,养殖期为7周。结果显示,饲料中添加5种核苷酸混合物对凡纳滨对虾的特定生长率(SGR)和饲料系数(FCR)影响不显著(P>0.05)。外源核苷酸显著影响凡纳滨对虾全虾水分含量(P<0.05),但对全虾粗蛋白、粗脂肪和灰分含量影响不显著(P>0.05)。肝胰指数(HSI)随饲料中核苷酸添加量的增加而显著升高(P<0.05),在0.6 g/kg组达到最高。0.4 g/kg组的肝胰腺谷草转氨酶(GOT)和谷丙转氨酶(GPT)活力及尿酸(UA)含量最低,但与对照组相比差异均不显著(P>0.05)。中肠肠壁厚度和肠绒毛高度均随着核苷酸添加量的增加呈先升高...     

凡纳滨幼虾采食不同蛋白水平日粮的免疫与消化率研究

在室内养殖条件下，进行单因素随机设计动物试验，即5种饲料蛋白质水平（31%、35%、39%、43%、47%；以A～E组表示）处理，投喂平均体质量0.2 g的凡纳滨幼虾，养殖60 d。研究结果表明，蛋白质营养对凡纳滨幼虾生长、免疫与抗氧化指标和消化率特征影响显著。随着饲料蛋白水平的升高，特定生长率显著增加，饲料系数下降，E组两项指标最好，分别为5.52和1.96。高蛋白质含量饲料有利于提高对虾免疫指标水平，血淋巴中血细胞浓度、T-AOC活力、POD活力、溶菌酶活力、总蛋白含量，随着蛋白质水平提高显著增加，各项指标E组最高，比A组分别显著提高133.7%、21%、16.8%、20.8%、19.7%(P<0.05)；而SOD活力C组最高，与A组差异显著。凡纳滨幼虾对蛋白质的消化率随饲料蛋白质含量增加显著升高(P<0.05),E组比A组提高8.2%。通过饲料蛋白质水平与特定生长的回归分析，获得凡纳滨对虾幼虾最大生长饲料蛋白质需要量为46.5％。     

Effect of dietary leucine on growth performance,hemolymph and hepatopancreas enzyme activities of swimming crab,Portunus trituberculatus

An 8‐week feeding trial was conducted to determine the dietary leucine requirement for juvenile swimming crabs reared in cement pools. Six isonitrogenous and isolipidic practical diets (430 g/kg crude protein and 70 g/kg crude lipid) were formulated to contain graded leucine levels which ranged from 16.7 to 26.7 g/kg (dry weight). Each diet was randomly assigned to triplicate groups of 60 juvenile swimming crabs (initial average weight 3.75 ± 0.12 g) that were stocked in rectangle plastic baskets. The results of the present study indicated that dietary leucine levels significantly influenced weight gain (WG) and specific growth ratio (SGR) (p < .05), crab fed the diet containing 22.7 g/kg leucine had significantly higher WG and SGR than those fed the other diets. Feed efficiency and protein efficiency ratio were not significantly affected by the dietary leucine levels (p > .05). Total protein, cholesterol, triglyceride and glucose in serum were significantly affected by the dietary leucine levels. Aspartate aminotransferase (AST) and alanine aminotransferase activities in hemolymph, AST and superoxide dismutase activities in hepatopancreas were significantly affected by dietary leucine levels; moreover, crab fed the 16.7 g/kg leucine diet had higher malondialdehyde in hemolymph and hepatopancreas than those fed the other diets. Crab fed the diet containing 24.9 g/kg leucine had higher phenoloxidase activity in hemolymph than those fed the other diets. Based on two‐slope broken‐line model of SGR against dietary leucine levels, the optimal dietary leucine requirement for growth was estimated to be 22.1 g/kg of the dry diet (corresponding to 51.4 g/kg of dietary protein on a dry weight basis). In summary, findings of this study indicated that dietary leucine could improve growth performance and antioxidant status.     

Effects of dietary astaxanthin on growth,antioxidant capacity and gene expression in Pacific white shrimp Litopenaeus vannamei

Pacific white shrimp Litopenaeus vannamei (1050 individuals with initial weight of 1.01 ± 0.001 g) were fed either control diet or one of six dietary astaxanthin (AX) concentration (25, 50, 75, 100, 125 and 150 mg kg⁻¹) diets for 56 days in 35 tanks (30 shrimp per tank). After 56 days of culture, shrimp‐fed AX125 and AX150 diets had higher (P < 0.05) weight gain, specific growth rate, total antioxidant status and lower (P < 0.05) superoxide dismutase (SOD), catalase (CAT) than shrimp fed control diet. After low dissolved oxygen stress for 1 h, survival rate of shrimp fed AX75, AX100, AX125 and AX150 diets was higher (P < 0.05) than that of shrimp fed control diet. Hypoxia inducible factor‐1α (HIF‐1α), cytosolic manganese superoxide dismutase (cMnSOD) and CAT mRNA expression levels of shrimp fed seven diets were significantly down‐regulated under hypoxia than under normoxia, but their expression levels were higher under hypoxia in shrimp fed AX‐supplemented diets than in shrimp fed control diet. About 70‐kDa heat‐shock protein (Hsp70) mRNA expression level of shrimp fed seven diets was significantly up‐regulated under hypoxia than under normoxia, but its expression level was lower under hypoxia in shrimp fed AX‐supplemented diets than in shrimp fed control diet.     

Hypoxia‐induced changes in survival,immune response and antioxidant status of the Pacific white shrimp (Litopenaeus vannamei) fed with graded levels of dietary myo‐inositol

A 3‐hr experiment was conducted to investigate the effects of dietary myo‐inositol (MI) supplementation on survival, immune response and antioxidant abilities in Litopenaeus vannamei under acute hypoxia stress. Six practical diets were formulated with supplementation of graded levels (control group 0, 0.1, 0.2, 0.4, 0.8 and 1.6 g/kg dry diet) of MI and were randomly assigned to triplicate groups of L. vannamei (mean weight 0.40 ± 0.00 g) for 8 weeks. Ten healthy shrimp (final mean weight approximately 11–14 g) randomly selected from each tank were exposed to hypoxia stress after feeding trial. After 3‐hr acute hypoxia stress, survival of shrimp fed MI‐supplemented diets (except 0.1 and 0.4 g/kg diets) was significantly increased compared with the control group. Shrimp fed control diet had lower activities of alkaline phosphatase (AKP), acid phosphatase (ACP), total antioxidant capacity (T‐AOC) and glutathione peroxidase (GPX), and higher malondialdehyde (MDA) and protein carbonyl (PC) contents in hepatopancreas than those fed the MI‐supplemented diets. In addition, mRNA expression levels of heat shock protein 70 (Hsp70), catalase (CAT) and penaeidin were significantly differentially regulated in hepatopancreas. In summary, dietary MI supplementation may have a positive effect on improving resistance to acute hypoxia stress of L. vannamei.     

Dietary nucleotide‐rich yeast supplementation improves growth,innate immunity and intestinal morphology of Pacific white shrimp (Litopenaeus vannamei)

An 8‐week feeding trial was conducted to evaluate the effects of dietary nucleotide (NT)‐rich yeast supplementation on growth, innate immunity and intestinal morphology in Pacific white shrimp (Litopenaeus vannamei). Four isonitrogenous and isolipidic practical diets were formulated to contain 0 (control), 10, 30 and 50 g/kg of NT‐rich yeast, respectively. A total of 480 shrimp with an average initial body weight of 1.86 ± 0.02 g were randomly allocated into four groups, with four replicates per group and 30 shrimp each replicate. The results indicated that shrimp fed the diet containing 50 g/kg NT‐rich yeast had significantly higher weight gain (WG), specific growth rate (SGR) and protein efficiency ratio (PER) than those fed the control diet, and the lowest feed conversion ratio (FCR) was observed in the shrimp fed the 50 g/kg NT‐rich yeast supplemental diet. However, there was no significant difference in survival among all treatments. The crude protein of whole shrimp in the 50 g/kg NT‐rich yeast group was higher than that in the control group. Total protein, triglyceride concentrations, the activities of aspartate aminotransferase and alanine aminotransferase in serum were significantly influenced by the dietary NT‐rich yeast supplementation. The activities of serum phenoloxidase (PO) and lysozyme (LZM) of shrimp fed the diet containing 50 g/kg NT‐rich yeast were higher than those in shrimp fed the other diets. Relative expressions of alp and lzm significantly upregulated in the 30 g/kg NT‐rich yeast group compared to the control group. The intestinal fold height and fold width in the 30 g/kg NT‐rich yeast group were significantly higher than those fed the control diet; and the highest microvillus height occurred in the shrimp fed the 50 g/kg NT‐rich yeast diet. In summary, dietary 30–50 g/kg NT‐rich yeast supplementation promotes growth performance, enhances innate immunity and improves intestinal morphology of Litopenaeus vannamei.     

Suitable dietary chitosan improves the growth performance,survival and immune function of tiger shrimp,Penaeus monodon

Different levels of dietary chitosan on growth performance, survival and stress tolerance to air exposure was studied in tiger shrimp, Penaeus monodon. Shrimp (mean initial wet weight about 1.16 g) were fed with six different diets (C0, C0.05, C0.1, C0.2, C0.3 and C0.4) containing six level of chitosan (0%, 0.05%, 0.1%, 0.2%, 0.3% and 0.4% respectively) in triplicate for 60 days. Growth performance [final body wet weight (FBW); weight gain (WG); biomass gain (BG)] of shrimp fed chitosan‐containing diets were higher (P < 0.05) than that of shrimp fed the basal diet, shrimp fed C0.1 diet showed the highest value of growth performance. Survival of shrimp in C0.1 and C0.2 diet groups were higher (P < 0.05) than that of shrimp in C0, C0.05 and C0.4 diet groups but without statistical difference (P > 0.05) in shrimp fed C0.3 diet group. Whole body and muscle lipid contents decreased with increasing dietary chitosan levels. Plasma total cholesterol and triglyceride contents of shrimp fed C0 diet was significantly higher (P < 0.05) than that of shrimp fed chitosan‐containing diets. Plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities of shrimp fed C0 diet were higher than those of shrimp fed chitosan‐containing diets. Digestive gland malondialdehyde (MDA) and carbonyl protein contents of shrimp fed chitosan‐containing diets were lower (P < 0.05) than that of shrimp fed C0 diet. Total haemocyte count of shrimp fed C0 diet was lower (P < 0.05) than that of shrimp fed chitosan‐containing diets. On the contrary, the haemolymph clotting time of shrimp fed C0 diet was higher (P < 0.05) than that of shrimp fed chitosan‐containing diets. In conclusion, all results suggested that dietary intake containing 0.1% and 0.2% chitosan enhanced the growth of shrimp, whereas a higher level than 0.3% and 0.4% decreased growth of shrimp. Second‐degree polynomial regression analysis of WG and BG indicated that the optimum supplement of dietary chitosan level should be 0.19–0.21%.     

Evaluation of a fish meal analogue as a replacement for fish meal in practical diets for Pacific white shrimp Litopenaeus vannamei

Three six‐week growth trials and a digestibility trial were conducted to evaluate a fish meal analogue (FMA) as a replacement for fish meal (FM) in shrimp feeds. Trials 1 and 2 evaluated and confirmed the potential of FMA supplementation (0, 48.5, 97, 145.5 and 194 g/kg) as a replacement for FM up to 200 g/kg without balancing for phosphorus (P) in practical diets for juvenile Pacific white shrimp L. vannamei. At the end of trial 1, shrimp offered diets containing 48.5 g/kg FMA exhibited significantly higher weight gain (WG) than those fed with the diet containing 145.5 g/kg FMA. At the end of trial 2, dietary FMA inclusion at 48.5 and 97 g/kg significantly improved WG and protein retention (PR), while reducing FCR and protein content of shrimp body compared to the diet containing 194 g/kg FMA. To determine whether P deficiency is the cause of reduced growth, the third trial was conducted utilizing equivalent diet but balanced for P. At the end of trial 3, shrimp fed diet containing 48.5 g/kg FMA+P showed significantly higher WG and PR than those fed diet containing 145.5 g/kg FMA+P. No decreasing trend of growth was detected in the diets containing FMA compared to the FM‐based diet. Apparent digestibility coefficients of dry matter, energy, protein and amino acids of FMA were determined using chromic oxide as an inert maker and the 70:30 replacement technique. The energy, protein and individual amino acid digestibility of FMA were significantly lower than those of soybean meal and FM which were run at the same time. Results of this work indicate that FMA can replace up to 200 g/kg FM in shrimp diets with supplemental inorganic P. Given the good growth across the range of inclusion without any indication of a growth depression, the low nutrient digestibility of FMA may be due to an atypical response or the product simply does not work with the testing technique.     

Comparative study on the utilization of crystalline methionine and methionine hydroxy analogue calcium by Pacific white shrimp (Litopenaeus vannamei Boone)

The objective of this study was to compare the supplemental effects of crystalline DL‐methionine (DL‐Met) and methionine hydroxy analogue calcium (MHA‐Ca) on growth performance of Pacific white shrimp. Eight isoproteinic (355.3 ± 2.0 g/kg diet) and isolipidic (70.0 ± 2.2 g/kg diet) diets were prepared as positive diet (20% fish meal), negative diet (15% fish meal) and DL‐Met, MHA‐Ca‐supplemented diets with the supplementation of 0.03%, 0.06%, 0.09% DL‐Met and 0.04%, 0.07%, 0.1% MHA‐Ca in negative diet respectively. Pacific white shrimp (0.92 ± 0.03 g) were fed one of the eight diets for 49 days. The results showed that dietary DL‐Met did not affect weight gain (WG) and feed conversion ratio (FCR) (p > 0.05), but the supplementation of 0.1% MHA‐Ca significantly increased WG, protein and lipid retention, and reduced FCR (p < 0.05) when compared to the negative group, and reached the similar levels as the positive control. The total free amino acids (TFAA) in haemolymph of MHA‐Ca groups and PC, NC group peaked at the 3rd hr after feeding, but the peaking time of DL‐Met groups was advanced to the 2nd hr. Activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in haemolymph of all MHA‐Ca groups peaked at the 2nd hr, but DL‐Met groups peaked at the 1st hr after feeding. The above results indicated that the supplementation of 0.1% MHA‐Ca in a low fish meal diet could improve the growth performance and feed utilization of Pacific white shrimp, but dietary DL‐Met did not significantly affect the growth.     

Utilization of fermented soybean meal for fishmeal substitution in diets of Pacific white shrimp (Litopenaeus vannamei)

Two feeding experiments were carried out to evaluate the utilization of fermented soybean meal (FSBM) in diets for Pacific white shrimp (Litopenaeus vannamei). The digestibility experiment was assessed with four diets: a reference diet and three ingredient test diets containing FSBM, local and Chilean fishmeal. The growth experiment was conducted including four isonitrogenous and isocaloric diets formulated to contain the graded levels of dietary fishmeal (0 g/kg, 150 g/kg, 300 g/kg and 450 g/kg) substituted by FSBM. The results indicated that ADCs of crude protein in FSBM were high (888.4 g/kg) and equal in local fishmeal but little lower than Chilean fishmeal while without any significant differences observed in ADCs of crude lipid among the different test ingredients. After 75 days of growth trial, survival rates and feed conversion ratio were not significantly different among the experimental treatments. However, shrimp fed the diets with increasing inclusions of FSBM had a tendency to reduce weight gain and specific growth rate. Based on the correlation between weight gain and substituted fishmeal level analysed by broken‐line regression, the optimum level of fishmeal replaced by FSBM in diet was 253.6 g/kg without adverse effects on growth and feed utilization of Pacific white shrimp.     

Use of plant‐based protein concentrates as replacement for fishmeal in practical diets for the Pacific white shrimp (Litopenaeus vannamei) reared under high stocking density and low salinity conditions

Two feeding trials were conducted to investigate the effect of replacing fishmeal with a combination of soy and corn protein concentrate (1:1 ratio) on growth performance of the Pacific white shrimp (Litopenaeus vannamei). A basal diet containing 200 g/kg fishmeal was systematically reduced (200, 150, 100, 50 and 0 g/kg) with protein concentrate on an isonitrogenous basis. Additionally, two diets containing 0 or 50 g/kg fishmeal were supplemented with lysine and methionine to evaluate possible limitations in EAAs. Each diet was randomly fed to five replicate tanks (15 shrimp per 75 L aquaria) reared in an indoor clear water system (Trial 1), or four replicate circular tanks (100 shrimp per 800 L) reared in outdoor green water system (Trial 2). In trial 1, results indicated a slight decrease in shrimp performance as fishmeal was replaced at the highest levels. Meanwhile, the supplementation of lysine and methionine to the diets did not result in shifts in survival, growth or FCR. In trial 2, there were no significant differences in growth performance across the tested diets. This study demonstrated that plant‐based protein concentrates can be used to replace fishmeal in practical shrimp diet in clear and green water under high stocking density.